Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey(患者様向け)
    • 妊娠前
    • 体外受精をはじめたら
    • 妊娠中
    • 出産後
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
[wpseo_breadcrumb]

Recurrent Pregnancy Loss Precision Panel

Recurrent Pregnancy Loss (RPL) is one of the most common obstetric complications, affecting more than 30% of conceptions. These can occur during preimplantation, pre–embryonic, embryonic, early fetal, late fetal and stillbirth. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Recurrent Pregnancy Loss (RPL) is one of the most common obstetric complications, affecting more than 30% of conceptions. These can occur during preimplantation, pre–embryonic, embryonic, early fetal, late fetal and stillbirth. An important number of losses are due to genetic abnormalities, nonetheless 50% of early pregnancy losses have been associated with chromosomal abnormalities. The majority are due to de novo non–disjunctional events during meiosis and balanced paternal translocations. Traditionally, the assessment of recurrent pregnancy loss was based on karyotyping techniques. However, advances in molecular genetic technology have provided an array of information regarding genetic causes and risk factors for pregnancy loss. One of the most innovative techniques with a significant role in RPL is preimplantation genetic testing in in vitro fertilization cycles.  

  • The Igenomix Recurrent Pregnancy Loss Precision Panel can be used to make a directed and accurate differential diagnosis of inability to carry out a full pregnancy ultimately leading to a better management and achieve a healthy baby at home. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Recurrent Pregnancy Loss Precision Panel is indicated for those patients the following manifestations: 
    • Inability to conceive after 1 year of unprotected intercourse  
    • Family history of infertility  
    • Personal history of recurrent miscarriages 
    • Family history of recurrent miscarriages 
    • Previous failed IVF cycles 
    • Other failed assisted reproductive technology (ART) treatments 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team for an initial consultation, workup and assisted reproductive technologies (ART). 
  • Risk assessment of asymptomatic family members according to the mode of inheritance.

Genes & Diseases

Methodology

References

See scientific referrals

age, J., & Silver, R. (2016). Genetic Causes Of Recurrent Pregnancy Loss. Clinical Obstetrics & Gynecology, 59(3), 498-508. Doi: 10.1097/Grf.0000000000000217 

Crotti, L., Tester, D. J., White, W. M., Bartos, D. C., Insolia, R., Besana, A., Kunic, J. D., Will, M. L., Velasco, E. J., Bair, J. J., Ghidoni, A., Cetin, I., Van Dyke, D. L., Wick, M. J., Brost, B., Delisle, B. P., Facchinetti, F., George, A. L., Schwartz, P. J., & Ackerman, M. J. (2013). Long QT syndrome-associated mutations in intrauterine fetal death. JAMA, 309(14), 1473–1482. https://doi.org/10.1001/jama.2013.3219 

Rajcan-Separovic E. (2020). Next generation sequencing in recurrent pregnancy loss-approaches and outcomes. European journal of medical genetics, 63(2), 103644. https://doi.org/10.1016/j.ejmg.2019.04.001 

Tur-Torres, M., Garrido-Gimenez, C., & Alijotas-Reig, J. (2017). Genetics of recurrent miscarriage and fetal loss. Best Practice & Research Clinical Obstetrics & Gynaecology, 42, 11-25. doi: 10.1016/j.bpobgyn.2017.03.007 

Hyde, K. J., & Schust, D. J. (2015). Genetic considerations in recurrent pregnancy loss. Cold Spring Harbor perspectives in medicine, 5(3), a023119. https://doi.org/10.1101/cshperspect.a023119 

Sultana, S., Nallari, P., & Ananthapur, V. (2020). Recurrent Pregnancy Loss (RPL): An overview. Journal Of Women’s Health And Development, 03(03). doi: 10.26502/fjwhd.2644-28840038 

Popescu, F., Jaslow, C., & Kutteh, W. (2018). Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Human Reproduction, 33(4), 579-587. doi: 10.1093/humrep/dey021 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policyNews and Press

Request Information


  • Patient Journey(患者様向け)
    • 妊娠前
    • 体外受精をはじめたら
    • 妊娠中
    • 出産後
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information

Llama gratis

Contáctanos